BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28111842)

  • 1. Detoxification of benzo[a]pyrene primarily depends on cytochrome P450, while bioactivation involves additional oxidoreductases including 5-lipoxygenase, cyclooxygenase, and aldo-keto reductase in the liver.
    Wang L; Xu W; Ma L; Zhang S; Zhang K; Ye P; Xing G; Zhang X; Cao Y; Xi J; Gu J; Luan Y
    J Biochem Mol Toxicol; 2017 Jul; 31(7):. PubMed ID: 28111842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to benzo[a]pyrene of Hepatic Cytochrome P450 Reductase Null (HRN) and P450 Reductase Conditional Null (RCN) mice: Detection of benzo[a]pyrene diol epoxide-DNA adducts by immunohistochemistry and 32P-postlabelling.
    Arlt VM; Poirier MC; Sykes SE; John K; Moserova M; Stiborova M; Wolf CR; Henderson CJ; Phillips DH
    Toxicol Lett; 2012 Sep; 213(2):160-6. PubMed ID: 22759596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice.
    Arlt VM; Stiborová M; Henderson CJ; Thiemann M; Frei E; Aimová D; Singh R; Gamboa da Costa G; Schmitz OJ; Farmer PB; Wolf CR; Phillips DH
    Carcinogenesis; 2008 Mar; 29(3):656-65. PubMed ID: 18204078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome b
    Reed L; Mrizova I; Barta F; Indra R; Moserova M; Kopka K; Schmeiser HH; Wolf CR; Henderson CJ; Stiborova M; Phillips DH; Arlt VM
    Arch Toxicol; 2018 Apr; 92(4):1625-1638. PubMed ID: 29368147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of cytochrome P450 oxidoreductase enhances metabolism and DNA adduct formation of benzo[a]pyrene in Hepa1c1c7 cells.
    Reed L; Jarvis IWH; Phillips DH; Arlt VM
    Mutagenesis; 2019 Dec; 34(5-6):413-420. PubMed ID: 31612222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced DNA adduct formation by benzo[a]pyrene in human liver cells lacking cytochrome P450 oxidoreductase.
    Reed L; Jarvis IWH; Phillips DH; Arlt VM
    Mutat Res Genet Toxicol Environ Mutagen; 2020 Apr; 852():503162. PubMed ID: 32265041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome b5 and epoxide hydrolase contribute to benzo[a]pyrene-DNA adduct formation catalyzed by cytochrome P450 1A1 under low NADPH:P450 oxidoreductase conditions.
    Stiborová M; Moserová M; Černá V; Indra R; Dračínský M; Šulc M; Henderson CJ; Wolf CR; Schmeiser HH; Phillips DH; Frei E; Arlt VM
    Toxicology; 2014 Apr; 318():1-12. PubMed ID: 24530354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of individual cytochrome P450 enzymes on oxidative metabolism of benzo[a]pyrene in human livers.
    Šulc M; Indra R; Moserová M; Schmeiser HH; Frei E; Arlt VM; Stiborová M
    Environ Mol Mutagen; 2016 Apr; 57(3):229-35. PubMed ID: 26919089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dioxin suppresses benzo[a]pyrene-induced mutations and DNA adduct formation through cytochrome P450 1A1 induction and (±)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide inactivation in human hepatoma cells.
    Shiizaki K; Kawanishi M; Yagi T
    Mutat Res; 2013 Jan; 750(1-2):77-85. PubMed ID: 23036853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of and DNA adduct formation by benzo[alpha]pyrene in human skin epithelial cells in vitro pretreated with cytochrome P450 modulators.
    Lehman TA; Kurian P; Milo GE
    Cancer Biochem Biophys; 1989 Oct; 10(4):345-52. PubMed ID: 2515917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of benzo[a]pyrene on metabolic activation of anticancer drug ellipticine in mice.
    Stiborova M; Cerna V; Moserova M; Arlt VM; Frei E
    Neuro Endocrinol Lett; 2013; 34 Suppl 2():43-54. PubMed ID: 24362092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competing roles of cytochrome P450 1A1/1B1 and aldo-keto reductase 1A1 in the metabolic activation of (+/-)-7,8-dihydroxy-7,8-dihydro-benzo[a]pyrene in human bronchoalveolar cell extracts.
    Jiang H; Shen YM; Quinn AM; Penning TM
    Chem Res Toxicol; 2005 Feb; 18(2):365-74. PubMed ID: 15720144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA adduct formation in precision-cut rat liver and lung slices exposed to benzo[a]pyrene.
    Harrigan JA; Vezina CM; McGarrigle BP; Ersing N; Box HC; Maccubbin AE; Olson JR
    Toxicol Sci; 2004 Feb; 77(2):307-14. PubMed ID: 14691214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in human B cell calcium homeostasis by polycyclic aromatic hydrocarbons: possible associations with cytochrome P450 metabolism and increased protein tyrosine phosphorylation.
    Mounho BJ; Burchiel SW
    Toxicol Appl Pharmacol; 1998 Mar; 149(1):80-9. PubMed ID: 9512730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 system expression and DNA adduct formation in the liver of Zacco platypus following waterborne benzo(a)pyrene exposure: implications for biomarker determination.
    Lee JW; Kim YH; Yoon S; Lee SK
    Environ Toxicol; 2014 Sep; 29(9):1032-42. PubMed ID: 23192953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro metabolism of benzo[a]pyrene by recombinant zebrafish CYP1A and liver microsomes from beta-naphthoflavone-treated rainbow trout.
    Miranda CL; Chung WG; Wang-Buhler JL; Musafia-Jeknic T; Baird WM; Buhler DR
    Aquat Toxicol; 2006 Nov; 80(2):101-8. PubMed ID: 16963132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzo[a]pyrene-induced toxicity: paradoxical protection in Cyp1a1(-/-) knockout mice having increased hepatic BaP-DNA adduct levels.
    Uno S; Dalton TP; Shertzer HG; Genter MB; Warshawsky D; Talaska G; Nebert DW
    Biochem Biophys Res Commun; 2001 Dec; 289(5):1049-56. PubMed ID: 11741297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic cytochrome P450 enzyme imprinting in adult rat by neonatal benzo[a]pyrene administration.
    Fujita I; Sindhu RK; Kikkawa Y
    Pediatr Res; 1995 May; 37(5):646-51. PubMed ID: 7603785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of hepatic P450 reductase null gpt delta mice in studying the role of hepatic P450 in genotoxic carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mutagenesis.
    Luan Y; Xing G; Qi X; Wu M; Li C; Yao J; Gong L; Nohmi T; Gu J; Zhou W; Zheng S; Ren J
    Arch Toxicol; 2012 Nov; 86(11):1753-61. PubMed ID: 22710403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene.
    Harrigan JA; McGarrigle BP; Sutter TR; Olson JR
    Toxicol In Vitro; 2006 Jun; 20(4):426-38. PubMed ID: 16198082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.